Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Sclerosis
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 298 active Multiple Sclerosis trials
SPINCOMS Biomarker Study
Study Type: Interventional
MBCT and CBT for Chronic Pain in Multiple Sclerosis
Study Type: Interventional
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
Study Type: Interventional Phase 2
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
Study Type: Interventional Phase 2
Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab
Study Type: Observational
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
Study Type: Interventional Phase 2
ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program
Study Type: Interventional
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers
Study Type: Interventional Phase 1
There are 298 active Multiple Sclerosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now